Systemic markers of inflammation are independently associated with S100B concentration: Results of an observational study in subjects with acute ischaemic stroke

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Beer, Christopher ^a,b,c,d   Blacker, David ^b,e   Bynevelt, Michael ^d,e   Hankey, Graeme J ^b,d   Puddey, Ian B ^b,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e SIR CHARLES GAIRDNER HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROTEIN S100B; BIOLOGICAL MARKER; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ACUTE DISEASE; AGED; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; BLOOD; INFLAMMATION; MIDDLE AGED; PATHOLOGY; STROKE;

AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; S100 PROTEINS; STROKE;

EID: 77958563830     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-71     Document Type: Article

References (29)

1. Cherian P, Hankey GJ, Eikelboom JW, Thom J, Baker RI, McQuillan A, Staton J, Yi Q. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 2003, 34:2132-2137. 10.1161/01.STR.0000086466.32421.F4, 12907813.
2. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397. 10.1016/S0166-2236(99)01401-0, 10441299.
3. Lip GYH, Blann AD, Farooqi IS, Zarifis J, Sagar G, Beevers DG. Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project. Blood Coagulation & Fibrinolysis 2002, 13:339-347.
4. Sanchez-Moreno C, Dashe JF, Scott T, Thaler D, Folstein MF, Martin A. Decreased Levels of Plasma Vitamin C and Increased Concentrations of Inflammatory and Oxidative Stress Markers After Stroke. Stroke 2004, 35:163-168. 10.1161/01.STR.0000105391.62306.2E, 14671251.
5. van Kooten F, Ciabattoni G, Patrono C, Dippel DWJ, Koudstaal PJ. Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. Stroke 1997, 28:1557-1563.
6. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004, 4:2. 10.1186/1471-2377-4-2, 331413, 14725719.
7. Kelly PJ, Morrow JD, Ning M, Koroshetz W, Lo EH, Terry E, Milne GL, Hubbard J, Lee H, Stevenson E, et al. Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study. Stroke 2008, 39:100-104. 10.1161/STROKEAHA.107.488189, 18063832.
8. Eikelboom JW, Hankey GJ, Baker RI, McQuillan A, Thom J, Staton J, Cole V, Yi Q. C-reactive protein in ischemic stroke and its etiologic subtypes. Journal of Stroke and Cerebrovascular Diseases 2003, 12:74-81. 10.1053/jscd.2003.16, 17903908.
9. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-Reactive Protein and Outcome After Ischemic Stroke. Stroke 1999, 30:981-985.
10. Audebert HJ, Pellkofer TS, Wimmer ML, Haberl RL. Progression in lacunar stroke is related to elevated acute phase parameters. Eur Neurol 2004, 51:125-131. 10.1159/000077012, 14988605.
11. Herrmann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci 2003, 21:177-190.
12. Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech 2003, 60:614-632. 10.1002/jemt.10303, 12645009.
13. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526. 10.1016/0140-6736(91)93206-O, 1675378.
14. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20:864-870.
15. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 1989, 42:703-709. 10.1016/0895-4356(89)90065-6, 2760661.
16. Bamford JM, Sandercock PA, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989, 20:828.
17. Mori TA, Croft KD, Puddey IB, Beilin LJ. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999, 268:117-125. 10.1006/abio.1998.3037, 10036170.
18. Jones SC, Bilous M, Winship S, Finn P, Goodwin J. Validation of the OSCAR 2 oscillometric 24-hour ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices. Blood Press Monit 2004, 9:219-223. 10.1097/00126097-200408000-00007, 15311149.
19. Goodwin J, Bilous M, Winship S, Finn P, Jones SC. Validation of the Oscar 2 oscillometric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol. Blood Press Monit 2007, 12:113-117. 10.1097/MBP.0b013e3280acab1b, 17353655.
20. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004, 109:2058-2067. 10.1161/01.CIR.0000127577.63323.24, 15078802.
21. Worthmann H, Tryc AB, Goldbecker A, Ma YT, Tountopoulou A, Hahn A, Dengler R, Lichtinghagen R, Weissenborn K. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome. Cerebrovasc Dis 2010, 30:85-92. 10.1159/000314624, 20484906.
22. Sienkiewicz-Jarosz H, Galecka-Wolska M, Bidzinski A, Turzynska D, Sobolewska A, Lipska B, Plaznik A, Ryglewicz D. Predictive value of selected biochemical markers of brain damage for functional outcome in ischaemic stroke patients. Neurol Neurochir Pol 2009, 43:126-133.
23. Sen J, Belli A. S100B in neuropathologic states: the CRP of the brain?. J Neurosci Res 2007, 85:1373-1380. 10.1002/jnr.21211, 17348038.
24. Portela LV, Brenol JC, Walz R, Bianchin M, Tort AB, Canabarro UP, Beheregaray S, Marasca JA, Xavier RM, Neto EC, et al. Serum S100B levels in patients with lupus erythematosus: preliminary observation. Clin Diagn Lab Immunol 2002, 9:164-166. 119880, 11777848.
25. Gross S, Homan van der Heide JJ, van Son WJ, Gans RO, Foell D, Navis G, Bakker SJ. Body mass index and creatinine clearance are associated with steady-state serum concentrations of the cell damage marker S100B in renal transplant recipients. Med Sci Monit 2010, 16:CR318-324.
26. Johnston KC, Wagner DP, Haley EC, Connors AF. Combined clinical and imaging information as an early stroke outcome measure. Stroke 2002, 33:466-472. 10.1161/hs0202.102881, 2749233, 11823654.
27. Adams HP, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999, 53:126-131.
28. Foerch C, Singer OC, Neumann-Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005, 62:1130-1134. 10.1001/archneur.62.7.1130, 16009772.
29. Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 2001, 18:491-498. 10.1089/089771501300227297, 11393252.